SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Review and Comparison of Methods for Recreating Individual Patient Data from Published Kaplan-Meier Survival Curves for Economic Evaluations: A Simulation Study
10 references·0 citing·35 second hop
A Review and Comparison of Methods for Recreating Individual Patient Data from Published Kaplan-Meier Survival Curves for Economic Evaluations: A Simulation Study (2015)A Review and Comparison of Methods for Re…Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial (2013)Survival Modeling for the Est…Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data (2013)Survival Analysis for Economi…Overview of Parametric Survival Analysis for Health-Economic Applications (2013)Overview of Parametric Surviv…Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves (2012)Enhanced secondary analysis o…Improved curve fits to summary survival data: application to economic evaluation of health technologies (2011)Improved curve fits to summar…Applied Methods of Cost-effectiveness Analysis in Healthcare (2010)Applied Methods of Cost-effec…Statistical Analysis of Cost‐effectiveness Data (2006)Statistical Analysis of Cost‐…Methodological issues in the economic analysis of cancer treatments (2006)Methodological issues in the …Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…Aggregate data meta‐analysis with time‐to‐event outcomes (2002)Aggregate data meta‐analysis …Cost-Effectiveness in Health and Medicine (1996)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)An Economic Evaluation of Cetuximab Combined with Radiotherapy for Patients with Locally Advanced Head and Neck Cancer in Belgium, France, Italy, Switzerland, and the United Kingdom (2008)Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma (2009)Measuring Outcomes in Palliative Care: Limitations of QALYs and the Road to PalYs (2009)A general parametric approach to the meta‐analysis of randomized clinical trials (1991)Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints (1998)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Choosing effect measures and computing estimates of effect (2019)IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves (2021)Practical methods for incorporating summary time-to-event data into meta-analysis (2007)First-line Nivolumab Plus Ipilimumab vs Sunitinib for Metastatic Renal Cell Carcinoma (2019)Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now? (2020)Meta-analysis in clinical trials (1986)The Handbook of Research Synthesis. (1994)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Utility approach to measuring health-related quality of life (1987)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial (2009)Health Economic Methods: Cost-Minimization, Cost-Effectiveness, Cost-Utility, and Cost-Benefit Evaluations (2011)Probabilistic sensitivity analysis in health economics (2011)Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆ (2017)Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer (2018)Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China (2021)Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting (2011)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)A Primer on Marginal Effects—Part I: Theory and Formulae (2014)Simulation and Matching-Based Approaches for Indirect Comparison of Treatments (2015)How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness (2019)Planning for Long-Term Follow-Up: Strategies Learned from Longitudinal Studies (2015)Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling (2016)Evidence Synthesis for Decision Making 2 (2012)Model Parameter Estimation and Uncertainty Analysis (2012)
this work references cited by second hop

References

  • 2006Decision Modelling For Health Economic Evaluation3,146 cited
  • 2012Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves2,587 cited
  • 2002Aggregate data meta‐analysis with time‐to‐event outcomes551 cited
  • 2013Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data541 cited
  • 2010Applied Methods of Cost-effectiveness Analysis in Healthcare343 cited
  • 2011Improved curve fits to summary survival data: application to economic evaluation of health technologies308 cited
  • 2006Statistical Analysis of Cost‐effectiveness Data155 cited
  • 2013Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial136 cited
  • 2013Overview of Parametric Survival Analysis for Health-Economic Applications133 cited
  • 2006Methodological issues in the economic analysis of cancer treatments107 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work